Position in NVCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$485,813
+$63,520 QoQ
Shares Held
44,570
+36.5% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
9 quarters on record
Voting authority
Sole 6.876822975095355.ToString("F0")%
Shared 0.ToString("F0")%
None 93.12317702490465.ToString("F0")%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026MERCER GLOBAL ADVISORS INC /ADV holds $222,746,178 across 50 Medical Devices names. NVCR ranks #20 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
539,567 | $55,397,343 | |
| 2 | MDT |
Medtronic plc
|
575,118 | $49,833,974 | |
| 3 | SYK |
Stryker Corp
|
150,940 | $49,597,374 | |
| 4 | EW |
Edwards Lifesciences Corp
|
260,717 | $20,878,217 | |
| 5 | BSX |
Boston Scientific Corp
|
195,951 | $12,295,925 | |
| 6 | PODD |
Insulet Corp
|
17,306 | $3,631,491 | |
| 7 | ATEC |
Alphatec Holdings, Inc.
|
305,118 | $3,319,683 | |
| 8 | DXCM |
Dexcom Inc
|
51,855 | $3,256,494 |
All Filings in NVCR
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $485,813 | 44,570 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $422,293 | 32,660 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $368,685 | 28,536 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $238,092 | 13,376 | Shares | Sole | 2025-08-14 | |
| 2022-03-31 | $270,670 | 3,267 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $208,046 | 2,771 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $359,197 | 3,092 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $632,852 | 2,853 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $284,980 | 2,156 | Shares | Sole | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||